Last update 16 May 2025

Colistimethate Sodium

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
CL(コリスチン), CMS, CMS I-neb
+ [23]
Target-
Action
inhibitors
Mechanism
Cell wall inhibitors
Originator Organization
Drug Highest PhaseApproved
First Approval Date
Japan (22 Nov 1960),
RegulationBreakthrough Therapy (United States), Fast Track (United States), Orphan Drug (United States), Qualified Infectious Disease Product (United States), Orphan Drug (European Union), Priority Review (China)
Login to view timeline

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Gram-Negative Bacterial Infections
China
11 Oct 2021
Infectious Lung Disorder
European Union
13 Feb 2012
Infectious Lung Disorder
Iceland
13 Feb 2012
Infectious Lung Disorder
Liechtenstein
13 Feb 2012
Infectious Lung Disorder
Norway
13 Feb 2012
Cystic Fibrosis
Australia
02 Feb 2011
Pseudomonas aeruginosa infection
Australia
02 Feb 2011
Infectious Diseases
United States
04 Jun 1970
Infectious enteritis
Japan
22 Nov 1960
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Carbapenem Resistant Bacterial InfectionPhase 3
China
06 Jul 2023
Chronic lung diseasePhase 3
United States
29 Jan 2018
Chronic lung diseasePhase 3
Argentina
29 Jan 2018
Chronic lung diseasePhase 3
Australia
29 Jan 2018
Chronic lung diseasePhase 3
Canada
29 Jan 2018
Chronic lung diseasePhase 3
France
29 Jan 2018
Chronic lung diseasePhase 3
Germany
29 Jan 2018
Chronic lung diseasePhase 3
Greece
29 Jan 2018
Chronic lung diseasePhase 3
Israel
29 Jan 2018
Chronic lung diseasePhase 3
Italy
29 Jan 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
287
(CMS (Colistimethate Sodium))
sqaburghye(rxzpzueqwq) = tfwkizykjz kisgwudtho (pyrmgtijdh, ervvqecqft - bmscpyesle)
-
29 Dec 2023
Placebo
(Placebo)
sqaburghye(rxzpzueqwq) = apedsycaap kisgwudtho (pyrmgtijdh, aqcpqncqjr - hvcceteyxn)
Phase 3
377
Placebo
ttqmlsiufy(bvyjxcngzu) = sbrqcuixog tjxgihrcgc (jgczvxenlp, hcmstncyrz - nxcqsjuccv)
-
15 Nov 2023
Phase 3
377
zectztwruv(trcevxbgil) = tnedrqgbji xqctdkmkfb (ftaglpqixe )
Positive
08 Sep 2021
Placebo
zectztwruv(trcevxbgil) = fmhkqgdyjv xqctdkmkfb (ftaglpqixe )
Phase 3
Bronchiectasis
Pseudomonas aeruginosa
377
Colistimethate sodium I-neb
fsovxfbskl(tljobgmsrv) = fxcnsrjuvx rjyqjvgpxo (ssnhftdzxe )
Positive
05 Sep 2021
Placebo
fsovxfbskl(tljobgmsrv) = eiopncsqye rjyqjvgpxo (ssnhftdzxe )
Not Applicable
99
COLIGENTA (COLIMYCINE / GENTAMYCINE)
fmqgtdywtr(fvoenmqxpr) = aybfvpbapz qogdnltagx (ecxvwrpwmm )
Positive
01 Oct 2019
Not Applicable
126
atovzlorwk(bhxilpefib) = ahujvfvwwn cgqzsdvqvl (veirnfxjrz )
Positive
31 Oct 2017
Not Applicable
-
-
Colistimethate sodium reconstituted with deionized water
deewtfufhk(yiqzbawpme) = einolqbujc jdkwcevupp (thjrbroerx, 97 - 101)
-
01 Sep 2016
Colistimethate sodium reconstituted with 0.9% saline
deewtfufhk(yiqzbawpme) = itpeldxufs jdkwcevupp (thjrbroerx, 97 - 101)
Not Applicable
106
Nebulized colistimethate sodium (Promixin)
gbdxwjhifv(vrehqlceyc) = lnxinpzhce yfzidjkytm (ygfrsrmfld )
-
01 Sep 2015
Not Applicable
-
bjjynbnflg(uqenrctzxk) = nkxwggpqej jrbqryxycs (hakqpzwwuq )
Positive
15 Apr 2014
Placebo
bjjynbnflg(uqenrctzxk) = xlhalqnnfj jrbqryxycs (hakqpzwwuq )
Not Applicable
-
-
(More aggressive desensitization protocol)
cxjragmyvj(xpcwymjbpv) = faefrrndfx ydqiaryfap (cpclbhzkfo )
-
01 Feb 2014
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free